Price
Financials
Standalone, Rs crore| Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14.97 | 17.49 | 13.91 | 12.17 | 4.61 | 0.96 | 0.15 | 0.32 | 0.60 | 0.45 | 0.45 | 0.35 |
| Expenses | 14.96 | 17.13 | 15.31 | 12.34 | 4.04 | 1.65 | 1.68 | 1.32 | 1.18 | 1.29 | 1.35 | 1.14 |
| Operating Profit | 0.01 | 0.36 | -1.40 | -0.17 | 0.57 | -0.69 | -1.53 | -1.00 | -0.58 | -0.84 | -0.90 | -0.79 |
| OPM % | 0.07% | 2.06% | -10.06% | -1.40% | 12.36% | -71.88% | -1,020.00% | -312.50% | -96.67% | -186.67% | -200.00% | -225.71% |
| Other Income | 0.01 | 0.16 | -6.56 | 0.04 | 0.12 | 0.06 | -7.53 | 0.02 | 0.09 | 0.02 | 0.27 | 0.06 |
| Interest | 0.03 | 0.05 | 0.29 | 0.08 | 0.14 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Depreciation | 0.74 | 0.75 | 0.71 | 0.57 | 0.57 | 0.58 | 0.57 | 0.52 | 0.59 | 0.45 | 0.44 | 0.38 |
| Profit before tax | -0.75 | -0.28 | -8.96 | -0.78 | -0.02 | -1.24 | -9.66 | -1.50 | -1.08 | -1.27 | -1.08 | -1.11 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.75 | -0.29 | -8.96 | -0.79 | -0.02 | -1.24 | -9.66 | -1.50 | -1.08 | -1.27 | -1.08 | -1.11 |
| EPS in Rs | -0.19 | -0.07 | -2.24 | -0.20 | -0.00 | -0.31 | -2.42 | -0.38 | -0.27 | -0.32 | -0.27 | -0.28 |
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 85.77 | 93.96 | 63.39 | 61.68 | 62.69 | 52.84 | 41.53 | 64.12 | 19.97 | 1.83 | 1.11 | 3.02 |
| Expenses | 83.97 | 90.20 | 66.31 | 60.10 | 62.06 | 55.13 | 46.68 | 65.97 | 21.80 | 5.12 | 2.51 | 5.05 |
| Operating Profit | 1.80 | 3.76 | -2.92 | 1.58 | 0.63 | -2.29 | -5.15 | -1.85 | -1.83 | -3.29 | -1.40 | -2.03 |
| OPM % | 2.10% | 4.00% | -4.61% | 2.56% | 1.00% | -4.33% | -12.40% | -2.89% | -9.16% | -179.78% | -126.13% | -67.22% |
| Other Income | 4.03 | 2.42 | 3.07 | 2.98 | 2.98 | -59.91 | -56.35 | -6.23 | -7.31 | 0.39 | 0.12 | 0.06 |
| Interest | 2.48 | 3.68 | 4.18 | 4.57 | 3.31 | 3.10 | 0.28 | 0.41 | 0.29 | 0.02 | 0.00 | 1.37 |
| Depreciation | 2.31 | 2.28 | 3.77 | 5.34 | 4.63 | 4.61 | 3.74 | 2.93 | 2.29 | 1.99 | 1.40 | 2.05 |
| Profit before tax | 1.04 | 0.22 | -7.80 | -5.35 | -4.33 | -69.91 | -65.52 | -11.42 | -11.72 | -4.91 | -2.68 | -5.39 |
| Tax % | 81.73% | -9.09% | -41.15% | -28.60% | -18.48% | 11.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.19 | 0.23 | -4.58 | -3.82 | -3.53 | -77.81 | -65.52 | -11.42 | -11.72 | -4.91 | -2.68 | -5.39 |
| EPS in Rs | 0.05 | 0.06 | -1.14 | -0.96 | -0.88 | -19.45 | -16.38 | -2.86 | -2.93 | -1.23 | -0.67 | -1.35 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -29% | -41% | -47% | 172% | ||
| Compounded Profit Growth | % | 7% | -11% | -101% | ||
| Stock Price CAGR | -6% | % | % | % | ||
| Return on Equity | % | % | % | -152% |
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 3.55 | 3.55 |
| Reserves | 143.17 | 132.34 | 127.66 | 123.67 | 120.16 | 36.07 | -29.53 | -40.90 | -52.42 | -57.32 | 0.00 | 0.00 |
| Borrowings | 22.40 | 31.43 | 36.86 | 28.15 | 31.16 | 26.13 | 24.90 | 23.92 | 23.67 | 24.07 | 13.39 | 19.21 |
| Other Liabilities | 28.13 | 48.47 | 27.26 | 9.45 | 9.37 | 15.16 | 25.50 | 26.44 | 6.60 | 10.56 | 2.04 | 5.09 |
| Total Liabilities | 233.70 | 252.24 | 231.78 | 201.27 | 200.69 | 117.36 | 60.87 | 49.46 | 17.85 | 17.31 | 18.98 | 27.85 |
| Fixed Assets | 16.01 | 25.63 | 28.16 | 23.46 | 20.69 | 20.08 | 16.48 | 13.66 | 11.37 | 9.38 | 8.96 | 12.51 |
| CWIP | 1.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.73 | 0.00 |
| Investments | 4.26 | 90.81 | 90.81 | 90.81 | 90.81 | 36.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 212.35 | 135.80 | 112.81 | 87.00 | 89.19 | 60.96 | 44.39 | 35.80 | 6.48 | 7.93 | 6.29 | 15.34 |
| Total Assets | 233.70 | 252.24 | 231.78 | 201.27 | 200.69 | 117.36 | 60.87 | 49.46 | 17.85 | 17.31 | 18.98 | 27.85 |
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -100.54 | 103.73 | 4.65 | 11.38 | 0.20 | 3.93 | 5.69 | 1.32 | -0.08 | 2.32 | -5.32 | -2.08 |
| Cash from Investing Activity | 8.95 | -108.26 | -6.42 | 1.69 | 1.22 | 5.10 | -0.97 | -0.25 | 0.55 | -2.94 | -0.21 | -1.85 |
| Cash from Financing Activity | 2.30 | 5.35 | 1.25 | -12.88 | -0.93 | -9.62 | -4.85 | -0.99 | -0.27 | 0.48 | 5.35 | 4.43 |
| Net Cash Flow | -89.29 | 0.82 | -0.52 | 0.19 | 0.49 | -0.60 | -0.12 | 0.08 | 0.20 | -0.14 | -0.18 | 0.49 |
| Free Cash Flow | -102.58 | 92.92 | -1.68 | 10.62 | -1.14 | 6.61 | 4.95 | 1.83 | -0.10 | 2.32 | -5.32 | -7.67 |
| CFO/OP | -5,586% | 2,759% | -159% | 737% | 63% | -211% | -110% | -71% | 4% | -71% | 380% | 102% |
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 246.31 | 257.59 | 253.47 | 157.29 | 177.93 | 137.25 | 147.92 | 101.55 | 4.57 | 31.91 | 29.59 | 204.25 |
| Inventory Days | 66.85 | 92.06 | 89.58 | 113.72 | 110.97 | 110.33 | 143.80 | 64.12 | 57.45 | 63.91 | 78.92 | 252.30 |
| Days Payable | 143.68 | 205.86 | 139.18 | 53.14 | 63.26 | 133.52 | 322.00 | 208.55 | 155.78 | 739.94 | 210.45 | 479.38 |
| Cash Conversion Cycle | 169.48 | 143.80 | 203.87 | 217.87 | 225.64 | 114.07 | -30.28 | -42.87 | -93.75 | -644.12 | -101.94 | -22.82 |
| Working Capital Days | 232.82 | 166.73 | 175.33 | 230.08 | 214.32 | 121.57 | -30.06 | -29.37 | -268.13 | -4,016.99 | -920.72 | -499.16 |
| ROCE % | 1.77% | 1.91% | -1.76% | -0.41% | -0.55% | -4.16% | -12.28% | -15.45% | -22.53% | -54.33% | -22.63% | -20.25% |
| Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 74.89% | 75.00% | 99.87% | 99.87% | 99.87% | 99.87% | 99.87% |
| No. of Shareholders | 19,019 | 18,655 | 18,770 | 18,739 | 18,696 | 18,658 | 18,634 | 20,279 | 23,979 | 24,026 | 27,357 | 29,298 |
Fundamentals
Market Cap₹ 16.8 Cr.
Current Price₹ 4.20
Book Value₹ 0.89
ROCE-20.2 %
ROE-152 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)172%
Compounded Profit Growth (TTM)-101%
Standalone figures.
Valuation
P/B, 3-year average-0.53x
P/B, 5-year average-3.42x
Profitability
Operating margin (excl. other income)-67.22%
Operating margin (incl. other income)-65.23%
EBITDA margin-70.81%
Pre-tax margin-245.41%
Net profit margin-245.41%
Net margin, latest quarter-317.14%
ROA-23.02%
ROE, 3-year average33.02%
ROCE, 3-year average-54.33%
ROA, 3-year average-21.91%
ROE, 5-year average-9.89%
ROCE, 5-year average-52.92%
ROA, 5-year average-24.25%
ROIC (approx.)-17.36%
Growth
Sales growth (latest year)172.07%
Sales CAGR, 3 years-46.72%
Sales CAGR, 5 years-40.80%
Sales growth QoQ-22.22%
Sales growth YoY (latest quarter)9.38%
Per share
EPS (TTM)Rs -1.14
EPS (latest year)Rs -15.18
EPS (latest quarter)Rs -0.28
EPS, 3-year averageRs -7.99
EPS, 5-year averageRs -5.95
Sales per shareRs 0.46
Cash flow per shareRs -0.52
Free cash flow per shareRs -1.92
Efficiency
Asset turnover0.11x
Fixed asset turnover0.24x
Inventory turnover1.85x
Inventory days198 days
Debtor days204 days
Debtors turnover1.79x
Creditor days479 days
Cash conversion cycle-23 days
Working capital days-499 days
Leverage
Total debtRs 19 Cr
Cash and bankRs 1 Cr
Net debtRs 18 Cr
Interest coverage-2.31x
Debt to assets68.98%
Cash flow
Cash from Operating Activity (latest year)Rs -2 Cr
Cash from Investing Activity (latest year)Rs -2 Cr
Cash from Financing Activity (latest year)Rs 4 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -8 Cr
FCFE (approx.: FCF + change in debt)Rs -2 Cr
Statement figures
Net sales (TTM)Rs 2 Cr
Net sales (latest year)Rs 3 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -2 Cr
Operating profit (latest quarter)Rs -1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -1 Cr
PBDT (TTM)Rs -3 Cr
Profit before tax (TTM)Rs -5 Cr
Net profit (TTM)Rs -5 Cr
Net profit (latest year)Rs -5 Cr
Net profit (latest quarter)Rs -1 Cr
Depreciation (TTM)Rs 2 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 3 Cr
Total expenditure (latest year)Rs 5 Cr
Total income (latest year)Rs 3 Cr
Share capitalRs 4 Cr
Total assetsRs 28 Cr
Net blockRs 13 Cr
ReceivablesRs 2 Cr
InventoryRs 2 Cr
Other liabilitiesRs 5 Cr
Shares outstanding (crore)4.00
Ownership
Promoter holding0.13% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 5 of 8| explain | Receivables outrunning sales Receivables grew 1778% vs sales +172% in 2023 |
| explain | Debt up, profit down Borrowings up 43% while net profit fell in 2023 |
| look | Inventory outrunning sales Inventory grew 525% vs sales +172% in 2023 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2021Sales ₹0 Cr +9.4% vs Jun 2020.
Net loss ₹1 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Syncom Healthcare Ltd?
Syncom Healthcare Ltd (533157) has a market capitalisation of Rs 16.8 Cr. at the close.
What were Syncom Healthcare Ltd's latest quarterly results?
In the Jun 2021 quarter, Syncom Healthcare Ltd sales was Rs 0 Cr (+9.4% vs Jun 2020) with a net loss of Rs 1 Cr.